Abstract:Objective: In this study, we evaluated the effect of supraclavicular lymph node dissection in breast cancer patients who presented with ipsilateral supraclavicular lymph node metastasis (ISLM) without distant metastasis. Methods: A total of 90 patients with synchronous ISLM without distant metastasis between 2000 and 2009 were retrospectively analyzed. Patients were retrospectively divided into two groups, namely supraclavicular lymph node dissection group(34 patients) and non-dissection group(56 patients), according to whether they underwentsupraclavicular lymph node dissection or not.The Kaplan-Meier method was applied to analyze the locoregional relapse free survival (LRFS) and overall survival(OS). Results: Median follow-upwas 85 months(range, 6 to 11 months). Local recurrence in 32 cases, 47 cases of distant metastasis, of which 25 patients were accompanied by both locoregional relapse and distant metastasis. Of the 32 patients with locoregional relapse, 11 patients were in the lymph node dissection group and 21 patients in the control group. Of the 47 patients with distant metastases, 17 were treated with lymph node dissection, 30 in the control group. Thirty-two patients died in the whole group and 16 patients underwentlymph node dissection and 16 patients didn't. There was no significant difference between the rate of 5-year LRFS and 5-year OS (P=0.359, P=0.246). For patients of ER negative, the 5-year loco-regional relapse free survival rates were 63.7% and 43.3% in supraclavicular lymph node dissection group and control group, respectively. The 5-year overall survival rates were 52.1% and 52.3%, respectively, and there were no statistically significant differences (P=0.118, P=0.951). For patients of PR negative, the 5-yearloco-regional relapse free rates were 59.8% and 46.2%, respectively, and the 5-year overall survival rates were 50.6% and 43.2%, respectively, and there was no significant difference between the two groups (P=0.317, P=0.973). The 5-year recurrence-free survival rates of human epidermal growth factor receptor 2 (HER2)-positive patients were 61.2% and 48.0%(P=0.634), respectively, and the 5-year overall survival rates were 37.2% and 65.4%(P=0.032). Forty-seven patients suffered distant metastases and the 5-year metastases free survival rates were 37.3% and 38.5% in supraclavicular lymph node dissection group and control group, respectively. Conclusion: Supraclavicular lymph node dissection maybe an effective approach to improve the loco-regional control for the patients with ISLM, especially for ER negative and PR negative subtypes, but it might has adverseeffects for the patients with negative HER2 status.

[The Effect of Axillary Lymph Node Status on the Prognosis of Patients with Local-Regional Recurrence after Breast-Conserving Surgery].

[Factor Analysis of Diagnosis and Surgical Treatment of Local Regional Recurrence in Breast Cancer Patients].

[Effect of axillary lymph node status on prognosis of different types of invasive breast cancer].

Combination Impact Of Axillary Lymph Node Status And Biological Subtypes On Prognosis And Breast Conserving Surgery In Locally-Invasive Breast Cancer: A Real-World Study Of A Chinese Population

Analysis of Prognosis-Related Factors of Local-Regional Recurrence Breast Cancer

The Value of Lymph Node Ratio in the Prediction of Rectal Cancer Patient Survival after Preoperative Chemoradiotherapy.

The effect and the analysis of local-regional recurrence factors for 62 patients with early-stage breast cancer after breast-conserving surgery

Effect of lymph node metastasis characteristics on local regional recurrence in stage pN1 non-small cell lung cancer

[The Role of Supraclavicular Lymph Node Dissection in Breast Cancer Patients with Synchronous Ipsilateral Supraclavicular Lymph Node Metastasis].

Effects of the status of lymph nodes metastasis on the prognosis of postoperative radiotherapy for patients with locally advanced esophageal squamous cell carcinoma

Clinicopathological Characteristics of Axillary Lymph Node Metastasis in Lung Cancer

[The Clinical Research of Local Recurrence after Breast-Conserving Therapy for Breast Cancer].

Effect of Nodal Status on Clinical Outcomes of Triple-Negative Breast Cancer: A Population-Based Study Using the Seer 18 Database

Effect of non-sentinel lymph node status on prognosis of Luminal B (HER2 negative) early breast cancer with positive sentinel lymph nodes

Prognostic Value Of Metastatic Axillary Lymph Node Ratio For Chinese Breast Cancer Patients

Using the lymph nodal ratio to predict the risk of locoregional recurrence in lymph node-positive breast cancer patients treated with mastectomy without radiation therapy

Role of radiotherapy and prognostic factors in breast cancer patients at high-risk of recurrence trea-ted with modified radical mastectomy and chemotherapy

Number of Negative Lymph Nodes Can Predict Survival after Postmastectomy Radiotherapy According to Different Breast Cancer Subtypes.

Effect of the Number of Positive Lymph Nodes and Lymph Node Ratio on Prognosis of Patients after Resection of Pancreatic Adenocarcinoma

Effect of Neoadjuvant Chemotherapy in Treatment of Locally Advanced Breast Cancer with Cytologically Proven Axillary Node Metastases

Positive metastasis axillary lymph nodes after radical mastectomy for breast cancer as an indication of postoperative radiotherapy